Study on the effectiveness of toborinone (OPC-18790) in the treatment of heart failure in patients following cardiac surgery

Arzneimittel-Forschung/Drug Research

Volumn 49, Issue 6, 1999, Pages 499-503

  Hirata, Takahiko ^a   Akamatsu, Tetsuya ^b   Horinokuchi, Noriko ^b   Uchida, Osamu ^b   Kuro, Masakazu ^b  

^a OSAKA GENERAL MEDICAL CENTER   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Cardiotonic agent; CAS 128667 95 8; Heart failure; OPC 18790; Toborinone, clinical studies

Indexed keywords

TOBORINONE;

ARTICLE; CENTRAL VENOUS PRESSURE; CLINICAL ARTICLE; DRUG EFFICACY; EXTRACORPOREAL CIRCULATION; HEART FAILURE; HEART RATE; HUMAN; POSTOPERATIVE COMPLICATION;

EID: 0032999592     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1300450     Document Type: Article

References (7)

1. Hosokawa, T., Mori, T., Fujiki, H., Cardiovascular actions of OPC-18790. Heart Vessels 7, 66 (1992)
2. 31P-MRS study. Cardiovase. Res. 30, 299 (1995)
3. Ohnishi, A., Toyoki, T., Ohno, T., Pharmacokinetics and pharmacodynamics of intravenous OPC-18790 in humans: A novel nonglycosidic inotropic agent. J. Clin. Pharmacol. 34, 176 (1994)
4. Feldman, M. D., Pak, P. H., Wu, C. C., Acute cardiovascular effects of OPC-18790 in patients with congestive heart failure. Circulation 93, 474 (1996)
5. Hines, R., The choice of inotropes following cardiopulmonary bypass. J. Cardiothoracic Vasc. Anesth. 5, 181 (1991)
6. Hess, W., Arnold, B., Veit, S., The haemodynamic effects of amrinone in patients with mitral stenosis and pulmonary hypertension. Europ. Heart J. 7, 800 (1986)
7. Wright, E. M., Sherry, K. M., Clinical and haemodynamic effects of milrinone in the treatment of low cardiac output after cardiac surgery. Brit. J. Anesth. 67, 585 (1991)